{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:47:23Z","timestamp":1789519643353,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7633","license":[{"start":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T00:00:00Z","timestamp":1481068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T00:00:00Z","timestamp":1481068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2016,12,15]]},"DOI":"10.1038\/nature20606","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T15:18:04Z","timestamp":1481037484000},"page":"462-465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":237,"title":["Intracellular allosteric antagonism of the CCR9 receptor"],"prefix":"10.1038","volume":"540","author":[{"given":"Christine","family":"Oswald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Rappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Dor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Errey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstie","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Deflorian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Jazayeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Congreve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona H.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,7]]},"reference":[{"key":"BFnature20606_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/BJ20101132","volume":"434","author":"JE Pease","year":"2011","unstructured":"Pease, J. E. Targeting chemokine receptors in allergic disease. Biochem. J. 434, 11\u201324 (2011)","journal-title":"Biochem. J."},{"key":"BFnature20606_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1146\/annurev-med-052010-145454","volume":"63","author":"TJ Wilkin","year":"2012","unstructured":"Wilkin, T. J. & Gulick, R. M. CCR5 antagonism in HIV infection: current concepts and future opportunities. Annu. Rev. Med. 63, 81\u201393 (2012)","journal-title":"Annu. Rev. Med."},{"key":"BFnature20606_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fimmu.2015.00012","volume":"6","author":"M Vela","year":"2015","unstructured":"Vela, M., Aris, M., Llorente, M., Garcia-Sanz, J. A. & Kremer, L. Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges. Front. Immunol. 6, 12 (2015)","journal-title":"Front. Immunol."},{"key":"BFnature20606_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ejphar.2014.06.060","volume":"746","author":"R Solari","year":"2015","unstructured":"Solari, R., Pease, J. E. & Begg, M. \u201cChemokine receptors as therapeutic targets: why aren\u2019t there more drugs?\u201d. Eur. J. Pharmacol. 746, 363\u2013367 (2015)","journal-title":"Eur. J. Pharmacol."},{"key":"BFnature20606_CR5","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1021\/jm300682j","volume":"55","author":"J Pease","year":"2012","unstructured":"Pease, J. & Horuk, R. Chemokine receptor antagonists. J. Med. Chem. 55, 9363\u20139392 (2012)","journal-title":"J. Med. Chem."},{"key":"BFnature20606_CR6","first-page":"119","volume":"8","author":"E Wendt","year":"2015","unstructured":"Wendt, E. & Keshav, S. CCR9 antagonism: potential in the treatment of inflammatory bowel disease. Clin. Exp. Gastroenterol. 8, 119\u2013130 (2015)","journal-title":"Clin. Exp. Gastroenterol."},{"key":"BFnature20606_CR7","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.cell.2016.08.015","volume":"166","author":"JP Changeux","year":"2016","unstructured":"Changeux, J. P. & Christopoulos, A. Allosteric modulation as a unifying mechanism for receptor function and regulation. Cell 166, 1084\u20131102 (2016)","journal-title":"Cell"},{"key":"BFnature20606_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1073\/pnas.0711253105","volume":"105","author":"MJ Serrano-Vega","year":"2008","unstructured":"Serrano-Vega, M. J., Magnani, F., Shibata, Y. & Tate, C. G. Conformational thermostabilization of the \u03b21-adrenergic receptor in a detergent-resistant form. Proc. Natl Acad. Sci. USA 105, 877\u2013882 (2008)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature20606_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuropharm.2010.07.001","volume":"60","author":"N Robertson","year":"2011","unstructured":"Robertson, N. et al. The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery. Neuropharmacology 60, 36\u201344 (2011)","journal-title":"Neuropharmacology"},{"key":"BFnature20606_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1124\/jpet.110.169714","volume":"335","author":"MJ Walters","year":"2010","unstructured":"Walters, M. J. et al. Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 335, 61\u201369 (2010)","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnature20606_CR11","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1126\/science.1241475","volume":"341","author":"Q Tan","year":"2013","unstructured":"Tan, Q. et al. Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science 341, 1387\u20131390 (2013)","journal-title":"Science"},{"key":"BFnature20606_CR12","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.1194396","volume":"330","author":"B Wu","year":"2010","unstructured":"Wu, B. et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066\u20131071 (2010)","journal-title":"Science"},{"key":"BFnature20606_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature12357","volume":"499","author":"K Hollenstein","year":"2013","unstructured":"Hollenstein, K. et al. Structure of class B GPCR corticotropin-releasing factor receptor 1. Nature 499, 438\u2013443 (2013)","journal-title":"Nature"},{"key":"BFnature20606_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nature17414","volume":"533","author":"A Jazayeri","year":"2016","unstructured":"Jazayeri, A. et al. Extra-helical binding site of a glucagon receptor antagonist. Nature 533, 274\u2013277 (2016)","journal-title":"Nature"},{"key":"BFnature20606_CR15","doi-asserted-by":"publisher","first-page":"22255","DOI":"10.1073\/pnas.1009633108","volume":"107","author":"B Tchernychev","year":"2010","unstructured":"Tchernychev, B. et al. Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells. Proc. Natl Acad. Sci. USA 107, 22255\u201322259 (2010)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature20606_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1124\/mol.107.039321","volume":"73","author":"G Andrews","year":"2008","unstructured":"Andrews, G., Jones, C. & Wreggett, K. A. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5. Mol. Pharmacol. 73, 855\u2013867 (2008)","journal-title":"Mol. Pharmacol."},{"key":"BFnature20606_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1124\/jpet.106.118927","volume":"322","author":"W Gonsiorek","year":"2007","unstructured":"Gonsiorek, W. et al. Pharmacological characterization of Sch527123, a potent allosteric CXCR1\/CXCR2 antagonist. J. Pharmacol. Exp. Ther. 322, 477\u2013485 (2007)","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnature20606_CR18","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/j.1476-5381.2009.00623.x","volume":"159","author":"K Salchow","year":"2010","unstructured":"Salchow, K. et al. A common intracellular allosteric binding site for antagonists of the CXCR2 receptor. Br. J. Pharmacol. 159, 1429\u20131439 (2010)","journal-title":"Br. J. Pharmacol."},{"key":"BFnature20606_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1365-2125.2011.03968.x","volume":"72","author":"AL Lazaar","year":"2011","unstructured":"Lazaar, A. L. et al. SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans. Br. J. Clin. Pharmacol. 72, 282\u2013293 (2011)","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BFnature20606_CR20","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1124\/mol.107.044610","volume":"74","author":"DJ Nicholls","year":"2008","unstructured":"Nicholls, D. J. et al. Identification of a putative intracellular allosteric antagonist binding-site in the CXC chemokine receptors 1 and 2. Mol. Pharmacol. 74, 1193\u20131202 (2008)","journal-title":"Mol. Pharmacol."},{"key":"BFnature20606_CR21","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1124\/jpet.108.148387","volume":"329","author":"P de Kruijf","year":"2009","unstructured":"de Kruijf, P. et al. Nonpeptidergic allosteric antagonists differentially bind to the CXCR2 chemokine receptor. J. Pharmacol. Exp. Ther. 329, 783\u2013790 (2009)","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnature20606_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/84224","volume":"2","author":"M Thelen","year":"2001","unstructured":"Thelen, M. Dancing to the tune of chemokines. Nature Immunol. 2, 129\u2013134 (2001)","journal-title":"Nature Immunol."},{"key":"BFnature20606_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.sbi.2011.06.002","volume":"21","author":"X Deupi","year":"2011","unstructured":"Deupi, X. & Standfuss, J. Structural insights into agonist-induced activation of G-protein-coupled receptors. Curr. Opin. Struct. Biol. 21, 541\u2013551 (2011)","journal-title":"Curr. Opin. Struct. Biol."},{"key":"BFnature20606_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pharmthera.2014.02.004","volume":"143","author":"BG Tehan","year":"2014","unstructured":"Tehan, B. G., Bortolato, A., Blaney, F. E., Weir, M. P. & Mason, J. S. Unifying family A GPCR theories of activation. Pharmacol. Ther. 143, 51\u201360 (2014)","journal-title":"Pharmacol. Ther."},{"key":"BFnature20606_CR25","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature10361","volume":"477","author":"SG Rasmussen","year":"2011","unstructured":"Rasmussen, S. G. et al. Crystal structure of the \u03b22 adrenergic receptor-Gs protein complex. Nature 477, 549\u2013555 (2011)","journal-title":"Nature"},{"key":"BFnature20606_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature14656","volume":"523","author":"Y Kang","year":"2015","unstructured":"Kang, Y. et al. Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser. Nature 523, 561\u2013567 (2015)","journal-title":"Nature"},{"key":"BFnature20606_CR27","unstructured":"Ungashe, S. et al. Aryl sulphonamides. US patent 2006\/0111351A1 (2006)"},{"key":"BFnature20606_CR28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/1471-2105-14-276","volume":"14","author":"T Nugent","year":"2013","unstructured":"Nugent, T. & Jones, D. T. Membrane protein orientation and refinement using a knowledge-based statistical potential. BMC Bioinformatics 14, 276\u2013285 (2013)","journal-title":"BMC Bioinformatics"},{"key":"BFnature20606_CR29","doi-asserted-by":"publisher","first-page":"W410","DOI":"10.1093\/nar\/gkw348","volume":"44","author":"V Alva","year":"2016","unstructured":"Alva, V. et al. The MPI bioinformatics Toolkit as an integrative platform for advanced protein sequence and structure analysis. Nucleic Acids Res. 44 (Suppl. W1), W410\u2013W415 (2016)","journal-title":"Nucleic Acids Res."},{"key":"BFnature20606_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.str.2006.01.013","volume":"14","author":"T Kawate","year":"2006","unstructured":"Kawate, T. & Gouaux, E. Fluorescence-detection size-exclusion chromatography for precrystallization screening of integral membrane proteins. Structure 14, 673\u2013681 (2006)","journal-title":"Structure"},{"key":"BFnature20606_CR31","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nprot.2009.31","volume":"4","author":"M Caffrey","year":"2009","unstructured":"Caffrey, M. & Cherezov, V. Crystallizing membrane proteins using lipidic mesophases. Nature Protocols 4, 706\u2013731 (2009)","journal-title":"Nature Protocols"},{"key":"BFnature20606_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1107\/S0907444909047374","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr. D 66, 133\u2013144 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature20606_CR33","doi-asserted-by":"crossref","unstructured":"Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760\u2013763 (1994)","DOI":"10.1107\/S0907444994003112"},{"key":"BFnature20606_CR34","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. D 69, 1204\u20131214 (2013)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature20606_CR35","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007)","journal-title":"J. Appl. Crystallogr."},{"key":"BFnature20606_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486\u2013501 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature20606_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213\u2013221 (2010)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature20606_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D 67, 355\u2013367 (2011)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature20606_CR39","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D 68, 352\u2013367 (2012)","journal-title":"Acta Crystallogr. D"},{"key":"BFnature20606_CR40","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1063\/1.467468","volume":"101","author":"GJ Martyna","year":"1994","unstructured":"Martyna, G. J., Tobias, D. J. & Klein, M. L. Constant pressure molecular dynamics algorithms. J. Chem. Phys. 101, 4177\u20134189 (1994)","journal-title":"J. Chem. Phys."},{"key":"BFnature20606_CR41","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1107\/S0907444913001121","volume":"69","author":"K Diederichs","year":"2013","unstructured":"Diederichs, K. & Karplus, P. A. Better models by discarding data? Acta Crystallogr. D 69, 1215\u20131222 (2013)","journal-title":"Acta Crystallogr. D"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature20606.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature20606","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature20606.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:58:09Z","timestamp":1684432689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature20606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,7]]},"references-count":41,"journal-issue":{"issue":"7633","published-print":{"date-parts":[[2016,12,15]]}},"alternative-id":["BFnature20606"],"URL":"https:\/\/doi.org\/10.1038\/nature20606","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,7]]},"assertion":[{"value":"3 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors are employees of Heptares Therapeutics and are shareholders of Sosei Group, the parent company of Heptares. Heptares is a drug discovery and development company working in the field of G-protein-coupled receptor structure-based drug design.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}